TREA

79414786 - AI-BOOST AFFINITY

Follow

Information

  • Trademark
  • 79414786
  • Serial Number
    79414786
  • Filing Date
    October 04, 2024
    a year ago
  • Transaction Date
    June 14, 2025
    4 months ago
  • Status Date
    May 24, 2025
    5 months ago
  • Status Code
    641
  • Current Location
    TMO LAW OFFICE 115
    Employee Name
    FLETCHER, TRACY
  • Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
AI-BOOST AFFINITY
Case File Statements
  • GS0091: Computer software used in the context of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; computer software used in the context of antibody discovery and identification; artificial intelligence software used in the context of drug discovery, affinity maturation, engineering of biological products, studies of molecular interactions, humanization and identification, drug research, antibody research and design, pharmaceutical research; machine learning software used in the context of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; downloadable software for research, diagnostics, genomics, proteomics, omics and biological products; big data generating software.
  • GS0421: Software as a service [SaaS] for a use in the field of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; medicine discovery services; biological research; scientific services and research in the field of drug discovery, affinity maturation, biological product engineering, studies of molecular interactions, humanization and identification, drug research, antibody, protein, peptide, biological and chemical research and design, pharmaceutical research; antibody sequencing; Research and development services related to AI in the field of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; research and development in the field of drug discovery and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals; research and development services in the field of antibody technology; electronic data storage; Software as a Service [SaaS] including software for machine learning.
Case File Event Statements
  • 1/16/2025 - 9 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 1/16/2025 - 9 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/20/2025 - 7 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/17/2025 - 9 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/26/2025 - 7 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/27/2025 - 7 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/24/2025 - 5 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/24/2025 - 5 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/13/2025 - 4 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT